Literature DB >> 22416266

Analysis of the VAV3 as candidate gene for schizophrenia: evidences from voxel-based morphometry and mutation screening.

Branko Aleksic1, Itaru Kushima, Ryota Hashimoto, Kazutaka Ohi, Masashi Ikeda, Akira Yoshimi, Yukako Nakamura, Yoshihito Ito, Tomo Okochi, Yasuhisa Fukuo, Yuka Yasuda, Motoyuki Fukumoto, Hidenaga Yamamori, Hiroshi Ujike, Michio Suzuki, Toshiya Inada, Masatoshi Takeda, Kozo Kaibuchi, Nakao Iwata, Norio Ozaki.   

Abstract

In recently completed Japanese genome-wide association studies (GWAS) of schizophrenia (JPN_GWAS) one of the top association signals was detected in the region of VAV3, a gene that maps to the chromosome 1p13.3. In order to complement JPN_GWAS findings, we tested the association of rs1410403 with brain structure in healthy individuals and schizophrenic patients and performed exon resequencing of VAV3. We performed voxel-based morphometry (VBM) and mutation screening of VAV3. Four independent samples were used in the present study: (1) for VBM analysis, we used case-control sample comprising 100 patients with schizophrenia and 264 healthy controls, (2) mutation analysis was performed on a total of 321 patients suffering from schizophrenia, and 2 case-control samples (3) 729 unrelated patients with schizophrenia and 564 healthy comparison subjects, and (4) sample comprising 1511 cases and 1517 healthy comparison subjects and were used for genetic association analysis of novel coding variants with schizophrenia. The VBM analysis suggests that rs1410403 might affect the volume of the left superior and middle temporal gyri (P=.011 and P=.013, respectively), which were reduced in patients with schizophrenia compared with healthy subjects. Moreover, 4 rare novel missense variants were detected. The mutations were followed-up in large independent sample, and one of the novel variants (Glu741Gly) was associated with schizophrenia (P=.02). These findings demonstrate that VAV3 can be seen as novel candidate gene for schizophrenia in which both rare and common variants may be related to increased genetic risk for schizophrenia in Japanese population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22416266      PMCID: PMC3627762          DOI: 10.1093/schbul/sbs038

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  29 in total

Review 1.  Voxel-based morphometry--the methods.

Authors:  J Ashburner; K J Friston
Journal:  Neuroimage       Date:  2000-06       Impact factor: 6.556

Review 2.  Signaling from axon guidance receptors.

Authors:  Greg J Bashaw; Rüdiger Klein
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03-24       Impact factor: 10.005

3.  I-TASSER: a unified platform for automated protein structure and function prediction.

Authors:  Ambrish Roy; Alper Kucukural; Yang Zhang
Journal:  Nat Protoc       Date:  2010-03-25       Impact factor: 13.491

4.  Genome-wide association study of schizophrenia in a Japanese population.

Authors:  Masashi Ikeda; Branko Aleksic; Yoko Kinoshita; Tomo Okochi; Kunihiro Kawashima; Itaru Kushima; Yoshihito Ito; Yukako Nakamura; Taro Kishi; Takenori Okumura; Yasuhisa Fukuo; Hywel J Williams; Marian L Hamshere; Dobril Ivanov; Toshiya Inada; Michio Suzuki; Ryota Hashimoto; Hiroshi Ujike; Masatoshi Takeda; Nick Craddock; Kozo Kaibuchi; Michael J Owen; Norio Ozaki; Michael C O'Donovan; Nakao Iwata
Journal:  Biol Psychiatry       Date:  2010-09-15       Impact factor: 13.382

5.  Common variants on chromosome 6p22.1 are associated with schizophrenia.

Authors:  Jianxin Shi; Douglas F Levinson; Jubao Duan; Alan R Sanders; Yonglan Zheng; Itsik Pe'er; Frank Dudbridge; Peter A Holmans; Alice S Whittemore; Bryan J Mowry; Ann Olincy; Farooq Amin; C Robert Cloninger; Jeremy M Silverman; Nancy G Buccola; William F Byerley; Donald W Black; Raymond R Crowe; Jorge R Oksenberg; Daniel B Mirel; Kenneth S Kendler; Robert Freedman; Pablo V Gejman
Journal:  Nature       Date:  2009-07-01       Impact factor: 49.962

6.  Copy number variation in schizophrenia in the Japanese population.

Authors:  Masashi Ikeda; Branko Aleksic; George Kirov; Yoko Kinoshita; Yoshio Yamanouchi; Tsuyoshi Kitajima; Kunihiro Kawashima; Tomo Okochi; Taro Kishi; Irina Zaharieva; Michael J Owen; Michael C O'Donovan; Norio Ozaki; Nakao Iwata
Journal:  Biol Psychiatry       Date:  2009-10-31       Impact factor: 13.382

7.  Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression.

Authors:  Raymond C K Chan; Xin Di; Grainne M McAlonan; Qi-yong Gong
Journal:  Schizophr Bull       Date:  2009-07-24       Impact factor: 9.306

Review 8.  Finding the missing heritability of complex diseases.

Authors:  Teri A Manolio; Francis S Collins; Nancy J Cox; David B Goldstein; Lucia A Hindorff; David J Hunter; Mark I McCarthy; Erin M Ramos; Lon R Cardon; Aravinda Chakravarti; Judy H Cho; Alan E Guttmacher; Augustine Kong; Leonid Kruglyak; Elaine Mardis; Charles N Rotimi; Montgomery Slatkin; David Valle; Alice S Whittemore; Michael Boehnke; Andrew G Clark; Evan E Eichler; Greg Gibson; Jonathan L Haines; Trudy F C Mackay; Steven A McCarroll; Peter M Visscher
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

9.  Anatomy of bipolar disorder and schizophrenia: a meta-analysis.

Authors:  Ian Ellison-Wright; Ed Bullmore
Journal:  Schizophr Res       Date:  2010-01-13       Impact factor: 4.939

10.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.

Authors:  Shaun M Purcell; Naomi R Wray; Jennifer L Stone; Peter M Visscher; Michael C O'Donovan; Patrick F Sullivan; Pamela Sklar
Journal:  Nature       Date:  2009-07-01       Impact factor: 49.962

View more
  8 in total

1.  A Conserved GEF for Rho-Family GTPases Acts in an EGF Signaling Pathway to Promote Sleep-like Quiescence in Caenorhabditis elegans.

Authors:  Amanda L Fry; Jocelyn T Laboy; Huiyan Huang; Anne C Hart; Kenneth R Norman
Journal:  Genetics       Date:  2016-01-22       Impact factor: 4.562

2.  Alteration in basal and depolarization induced transcriptional network in iPSC derived neurons from Timothy syndrome.

Authors:  Yuan Tian; Irina Voineagu; Sergiu P Paşca; Hyejung Won; Vijayendran Chandran; Steve Horvath; Ricardo E Dolmetsch; Daniel H Geschwind
Journal:  Genome Med       Date:  2014-10-10       Impact factor: 11.117

Review 3.  Regulating Rac in the nervous system: molecular function and disease implication of Rac GEFs and GAPs.

Authors:  Yanyang Bai; Xiaoliang Xiang; Chunmei Liang; Lei Shi
Journal:  Biomed Res Int       Date:  2015-03-24       Impact factor: 3.411

4.  VAV-1 acts in a single interneuron to inhibit motor circuit activity in Caenorhabditis elegans.

Authors:  Amanda L Fry; Jocelyn T Laboy; Kenneth R Norman
Journal:  Nat Commun       Date:  2014-11-21       Impact factor: 14.919

5.  Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors.

Authors:  Nuria Perretta-Tejedor; Javier Fernández-Mateos; Luis García-Ortiz; Manuel A Gómez-Marcos; José I Recio-Rodríguez; Cristina Agudo-Conde; Emiliano Rodriguez-Sánchez; Ana I Morales; Francisco J López-Hernández; José M López-Novoa; Rogelio González-Sarmiento; Carlos Martínez-Salgado
Journal:  Sci Rep       Date:  2017-02-03       Impact factor: 4.379

6.  Deletion of the Nucleotide Exchange Factor Vav3 Enhances Axonal Complexity and Synapse Formation but Tampers Activity of Hippocampal Neuronal Networks In Vitro.

Authors:  David Wegrzyn; Christine Wegrzyn; Kerry Tedford; Klaus-Dieter Fischer; Andreas Faissner
Journal:  Int J Mol Sci       Date:  2020-01-28       Impact factor: 5.923

7.  Vav3-Deficient Astrocytes Enhance the Dendritic Development of Hippocampal Neurons in an Indirect Co-culture System.

Authors:  David Wegrzyn; Josephine Zokol; Andreas Faissner
Journal:  Front Cell Neurosci       Date:  2022-02-14       Impact factor: 5.505

Review 8.  Vav family exchange factors: an integrated regulatory and functional view.

Authors:  Xosé R Bustelo
Journal:  Small GTPases       Date:  2014
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.